Abstract:Background: Elevated plasma Lp-PLA 2 (lipoprotein-associated phospholipase A 2 ) activity is closely associated with an increased risk of cardiovascular events. However, whether and how Lp-PLA 2 is directly involved in the pathogenesis of atherosclerosis is still unclear. To examine the hypothesis that Lp-PLA 2 could be a potential preventative target of atherosclerosis, we generated Lp-PLA 2 knockout rabbits and investigated the pathophysiological functions of Lp-PLA 2 . Methods: Lp-PLA 2 knockout rabbits were generated using CRISPR/Cas9 system to assess the role of Lp-PLA 2 in plasma lipids regulation and identify its underlying molecular mechanisms. Homozygous knockout rabbits along with wild-type rabbits were fed a cholesterol-rich diet for up to 14 weeks and their atherosclerotic lesions were compared. Moreover, the effects of Lp-PLA 2 deficiency on the key cellular behaviors in atherosclerosis were assessed in vitro. Results: When rabbits were fed a standard diet, Lp-PLA 2 deficiency led to a significant reduction in plasma lipids. The decreased protein levels of SREBP2 (sterol regulatory element-binding protein 2) and HMGCR (3-hydroxy-3-methylglutaryl coenzyme A reductase) in livers of homozygous knockout rabbits indicated that the cholesterol biosynthetic pathway was impaired with Lp-PLA 2 deficiency. In vitro experiments further demonstrated that intracellular Lp-PLA 2 efficiently enhanced SREBP2-related cholesterol biosynthesis signaling independently of INSIGs (insulin-induced genes). When fed a cholesterol-rich diet, homozygous knockout rabbits exhibited consistently lower level of hypercholesterolemia, and their aortic atherosclerosis lesions were significantly reduced by 60.2% compared with those of wild-type rabbits. The lesions of homozygous knockout rabbits were characterized by reduced macrophages and the expression of inflammatory cytokines. Macrophages of homozygous knockout rabbits were insensitive to M1 polarization and showed reduced DiI-labeled lipoprotein uptake capacity compared with wild-type macrophages. Lp-PLA 2 deficiency also inhibited the adhesion between monocytes and endothelial cells. Conclusions: These results demonstrate that Lp-PLA 2 plays a causal role in regulating blood lipid homeostasis and Lp-PLA 2 deficiency protects against dietary cholesterol-induced atherosclerosis in rabbits. Lp-PLA 2 could be a potential target for the prevention of atherosclerosis.

Apolipoprotein CIII Deficiency Protects Against Atherosclerosis in Knockout Rabbits

CRISPR/Cas9-mediated knockout of APOC3 stabilizes plasma lipids and inhibits atherosclerosis in rabbits

Hypertriglyceridemia and Delayed Clearance of Fat Load in Transgenic Rabbits Expressing Human Apolipoprotein CIII

Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice

Targeting ApoC3 Paradoxically Aggravates Atherosclerosis in Hamsters With Severe Refractory Hypercholesterolemia

ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors

Aggravated Restenosis and Atherogenesis in ApoCIII Transgenic Mice but Lack of Protection in ApoCIII Knockouts: the Effect of Authentic Triglyceride-Rich Lipoproteins with and Without ApoCIII.

Lp-PLA 2 (Lipoprotein-Associated Phospholipase A 2 ) Deficiency Lowers Cholesterol Levels and Protects Against Atherosclerosis in Rabbits

Human apolipoprotein A-II reduces atherosclerosis in knock-in rabbits

[The Role of Apolipoprotein C3 in the Regulation of Nonalcoholic Fatty Liver Disease, Glucose and Lipid Metabolism, and Islet Β Cell Function].

ClC-3 deficiency prevents atherosclerotic lesion development in ApoE−/− mice

Overexpression of CCN3 inhibits inflammation and progression of atherosclerosis in apolipoprotein E-deficient mice

Human apolipoprotein A-II protects against diet-induced atherosclerosis in transgenic rabbits

Ablation of Interferon Regulatory Factor 3 Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice

Reduced high density lipoprotein cholesterol in severe hypertriglyceridemic ApoCIII transgenic mice via lowered hepatic ApoAI synthesis.

Dickkopf-3 Ablation Attenuates the Development of Atherosclerosis in ApoE-Deficient Mice.

Human Apolipoprotein A-I Exerts a Prophylactic Effect on High-Fat Diet-Induced Atherosclerosis Via Inflammation Inhibition in a Rabbit Model

Abstract 13320: APOO Knockout Elevates Plasma Cholesterol Levels Independent of LDLR and Accelerates Atherosclerosis in Mice

Abstract 1952: ABCA1 Deficency Diminishes Dysfunctional HDL and Inhibits Early Atherosclerotic Lesion Development in SR-BI Knockout Mice

Apolipoprotein CIII Regulates Lipoprotein-Associated Phospholipase A2 Expression Via the MAPK and NFκB Pathways

Lipid-Free Apolipoprotein A-I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio